» Articles » PMID: 27907132

A Simplified and Efficient Process for Insulin Production in Pichia Pastoris

Overview
Journal PLoS One
Date 2016 Dec 2
PMID 27907132
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

A significant barrier to insulin is affordability. In this manuscript we describe improvements to key steps in the insulin production process in Pichia pastoris that reduce cost and time. The strategy for recovery and processing of human insulin precursor has been streamlined to two steps from bioreactor to the transpeptidation reaction. In the first step the insulin precursor secreted during the methanol induction phase is recovered directly from the culture broth using Tangential Flow Filtration with a Prostak™ module eliminating the laborious and time-consuming multi-step clarification, including centrifugation. In the second step the protein is applied at very high loadings on a cation exchange resin and eluted in a mixture of water and ethanol to obtain a concentrated insulin precursor, suitable for use directly in the transpeptidation reaction. Overall the yield from insulin precursor to human insulin was 51% and consisted of three purification chromatography steps. In addition we describe a method for recovery of the excess of H-Thr(tBu)-OtBu from the transpeptidation reaction mixture, one of the more costly reagents in the process, along with its successful reuse.

Citing Articles

A simple and effective method to remove pigments from heterologous secretory proteins expressed in Pichia pastoris.

Li T, Cai H, Lai Y, Yao H, Li D Adv Biotechnol (Singap). 2025; 2(1):5.

PMID: 39883296 PMC: 11740859. DOI: 10.1007/s44307-024-00013-z.


Therapeutic proteins: developments, progress, challenges, and future perspectives.

Kumar V, Barwal A, Sharma N, Mir D, Kumar P, Kumar V 3 Biotech. 2024; 14(4):112.

PMID: 38510462 PMC: 10948735. DOI: 10.1007/s13205-024-03958-z.


Large-scale crystallization as an intermediate processing step in insulin downstream process: explored advantages and identified tool for process intensification.

Hazra P, Buddha M, Reddy C, Gupta I Bioprocess Biosyst Eng. 2023; 46(12):1765-1776.

PMID: 37938390 DOI: 10.1007/s00449-023-02931-z.


Advances in Metabolic Engineering of Strains as Powerful Cell Factories.

Zha J, Liu D, Ren J, Liu Z, Wu X J Fungi (Basel). 2023; 9(10).

PMID: 37888283 PMC: 10608127. DOI: 10.3390/jof9101027.


Full-length versus truncated α-factor secretory signal sequences for expression of recombinant human insulin precursor in yeast Pichia pastoris: a comparison.

Utami N, Nurdiani D, Hariyatun H, Putro E, Patria F, Kusharyoto W J Genet Eng Biotechnol. 2023; 21(1):67.

PMID: 37212962 PMC: 10203085. DOI: 10.1186/s43141-023-00521-w.


References
1.
Pais J, Varas L, Valdes J, Cabello C, Rodriguez L, Mansur M . Modeling of mini-proinsulin production in Pichia pastoris using the AOX promoter. Biotechnol Lett. 2003; 25(3):251-5. DOI: 10.1023/a:1022398917213. View

2.
Babu P, Srinivas V, Mohan V, Krishna E . Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli. J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 861(2):218-26. DOI: 10.1016/j.jchromb.2007.10.008. View

3.
Rose K, De Pury H, Offord R . Rapid preparation of human insulin and insulin analogues in high yield by enzyme-assisted semi-synthesis. Biochem J. 1983; 211(3):671-76. PMC: 1154412. DOI: 10.1042/bj2110671. View

4.
Mansur M, Cabello C, Hernandez L, Pais J, Varas L, Valdes J . Multiple gene copy number enhances insulin precursor secretion in the yeast Pichia pastoris. Biotechnol Lett. 2005; 27(5):339-45. DOI: 10.1007/s10529-005-1007-7. View

5.
Urmann M, Graalfs H, Joehnck M, Jacob L, Frech C . Cation-exchange chromatography of monoclonal antibodies: characterisation of a novel stationary phase designed for production-scale purification. MAbs. 2010; 2(4):395-404. PMC: 3180086. DOI: 10.4161/mabs.12303. View